Hunter Associates Investment Management’s Acer Therapeutics Inc ACER Stock Holding History

Hunter Associates Investment Management’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,000	Closed	-$49K	–	263
2023 Q3	$49K	Hold	60,000	–	–	0.01%	246
2023 Q2	$55K	Buy	60,000 +41,000	+216%	+$36.3K	0.01%	245
2023 Q1	$14K	Hold	19,000	–	–	﹤0.01%	255
2022 Q4	$48K	Hold	19,000	–	–	0.01%	225
2022 Q3	$26K	Hold	19,000	–	–	0.01%	217
2022 Q2	$24K	Buy	+19,000	New	+$39.8K	0.01%	221

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Hunter Associates Investment Management's ACER Position: Q4 2023 in Review

Hunter Associates Investment Management sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 60,000 shares — an estimated $49K sold.

Hunter Associates Investment Management first reported a position in ACER in Q2 2022 and held it in 6 quarters. The position peaked at $55K in Q2 2023. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Hunter Associates Investment Management reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Hunter Associates Investment Management sold 60,000 Acer Therapeutics Inc shares in Q4 2023, an estimated $49K.
Hunter Associates Investment Management first reported a position in Acer Therapeutics Inc in Q2 2022 and held it in 6 quarters.
Hunter Associates Investment Management's Acer Therapeutics Inc position peaked at $55K in Q2 2023.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Hunter Associates Investment Management's 13F filing for Q4 2023, filed 31 Jan 2024.